Prana raises US$3.7 million

By Staff writer
Wednesday, 08 December, 2004

A number of US institutional investors have purchased and exercised 9.5 million options in Prana Biotechnology (NASDAQ: PRAN, ASX: PBT) at $0.50 per share, raising US$3.7 million for the company.

The options - originally owned by directors and insiders of Prana - were exercised prior to their scheduled expiry date of December 1, 2004.

The exercise of options increases the total issued shares in Prana to 126,890,821.

Hormone therapy shifts body proteins to match gender identity

Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...

Targeting 'molecular bodyguards' weakens prostate cancer cells

Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...

Females found to carry a higher genetic risk of depression

An international team of scientists has discovered about twice as many genetic 'flags'...

Content from other channels on our network

Nurse turns to teaching health care's next generation

Doctors criticise "risky prescribing agenda"

Keeping Infection Prevention Front of Mind – Every Day of the Year

WA invests $1.5bn in three major new public hospital projects

Framework seeks to cut medicine errors at transitions of care

Submissions wanted for tyre industry inquiry

Researchers to create 'affordable' jet fuel from plant waste

AI may have devastating impact on bees: study

Discovery improves silicon solar efficiency

Partnership to redefine thermal comfort index

Best 'young red' awarded to a windswept vineyard in Tassie

Roma Foods celebrates over 70 years of Australian manufacturing

Rock lobster exporter improves supply chain efficiency

Butter maker required sanitary measurement solution

CCEP's reverse vending machine rollout